Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation) - Ostinelli EG, Jajawi S, Spyridi S, Sayal K, Jayaram MB.
BACKGROUND: People experiencing psychosis may become aggressive. Antipsychotics, such as aripiprazole in intramuscular form, can be used in such situations. OBJECTIVES: To evaluate the effects of intramuscular aripiprazole in the treatment of psych... (Source: SafetyLit)
Source: SafetyLit - January 15, 2018 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news
Pharma news in clinical trials, chronic condition management, and innovation from Q4 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka ’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health, and, more generally, innovation. (Source: mobihealthnews)
Source: mobihealthnews - December 27, 2017 Category: Information Technology Source Type: news
Gene Polymorphisms and Aripiprazole-induced Autonomic Dysfunction Gene Polymorphisms and Aripiprazole-induced Autonomic Dysfunction
Certain polymorphisms in the ABCB1 gene appear to be linked to aripiprazole-induced autonomic nervous system dysfunction in patients with schizophrenia, researchers from Japan report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 20, 2017 Category: Pathology Tags: Psychiatry News Source Type: news
Abilify MyCite (Aripiprazole Tablets with Sensor) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 27, 2017 Category: Drugs & Pharmacology Source Type: news
In-Depth: How digital sensors could change the face of pharma
Earlier this week, Proteus Digital Health and Otsuka Pharmaceuticals announced that Abilify MyCite, a new, sensor-enabled version of Otsuka ’s drug for schizophrenia, had received FDA approval for mental health conditions including schizophrenia and bipolar disorder. (Source: mobihealthnews)
Source: mobihealthnews - November 17, 2017 Category: Information Technology Source Type: news
FDA Approves First Pill with Digital Tracker
The FDA has approved a new version of the antipsychotic aripiprazole embedded with a digital sensor to allow patients to track when the medication was... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 15, 2017 Category: Primary Care Source Type: news
Digital pill could address a "big problem" with medication
CBS News chief medical correspondent Dr. Jon LaPook explains how the digital pill, Abilify MyCite, works (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 15, 2017 Category: Consumer Health News Source Type: news
Otsuka, Proteus finally win FDA approval for sensor-equipped Abilify
The first drug in the US with a digital ingestion tracking system has been approved by the FDA.
The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults. (Source: mobihealthnews)
Source: mobihealthnews - November 14, 2017 Category: Information Technology Source Type: news
FDA approves first trackable pill that syncs with a phone
The FDA approved a pill that tracks when patients take their prescribed psychiatric drug. The medication, Abilify MyCite, is a variation on a drug used to treat schizophrenia and bipolar disorder. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news
FDA Clears Drug With Ingestible Digital Tracker FDA Clears Drug With Ingestible Digital Tracker
Abilify MyCite is the first drug approved in the United States that has a digital tracking system for patients and providers to monitor medication intake.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2017 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news
'Digital Pill' Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. (Source: WebMD Health)
Source: WebMD Health - November 14, 2017 Category: Consumer Health News Source Type: news
FDA OKs First 'Digital Pill' That Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. (Source: WebMD Health)
Source: WebMD Health - November 14, 2017 Category: Consumer Health News Source Type: news
FDA approves first pill with sensor to track ingestion
The FDA today approved Abilify MyCite, the first drug in the U.S. to have an ingestible sensor embedded within the pill that can track if the medication was taken.
The drug-device combination product is indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes linked with bipolar I disorder and as an add-on treatment for depression in adults.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA approves first pill with sensor to track ingestion appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Neurological Patient Monitoring Pharmaceuticals Regulatory/Compliance Wall Street Beat Otsuka Pharmaceutical Proteus Digital Health Source Type: news
' Digital Pill', Abilify Mycite, Tells Doctor When Patient Takes It
TUESDAY, Nov. 14, 2017 -- The first drug designed to alert a doctor when a patient takes the medication has been approved by the U.S. Food and Drug Administration.
Abilify MyCite (aripiprazole with sensor) has an embedded sensor that sends a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2017 Category: General Medicine Source Type: news
FDA OKs First'Digital Pill', Abilify Mycite, That Lets Doctors Know It's Been Taken
TUESDAY, Nov. 14, 2017 -- Offering both the promise of better patient compliance with health care, but also fears of a medical " Big Brother, " a newly approved " digital pill " allows physicians to track whether or not it ' s been ingested by... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2017 Category: General Medicine Source Type: news
